Developing the “male IUD” with Kevin Eisenfrats from Contraline
Listen now
Description
Clinical trials are ongoing for the first long-lasting, reversible male birth control which is the first innovation in male birth control since the vasectomy hit the scene in 1897. This week’s Found guest is Kevin Eisenfrats, the co-founder and CEO of Contraline, a biotech company developing innovative methods to use hydrogel as a contraceptive. Contraline’s first product, ADAM, is what some are calling the first male IUD. The company will begin clinical trials in the U.S. very soon.
More Episodes
This week on Found, Dom and Becca are diving into the world of data governance with Collibra CEO Felix Van de Maele. They get into how maintaining organized data started as a niche concept and became the bedrock of AI and privacy compliance. They also talk about the early challenges of building a...
Published 11/19/24
Published 11/19/24
In this episode, Dom and Becca dive into the future of trucking with Raquel Urtasun, CEO and co-founder of Waabi, a company pioneering driverless, long-haul trucks powered by generative AI. They talked about Waabi's unique simulation-based training approach, its vision for autonomous technology,...
Published 11/12/24